DOI QR코드

DOI QR Code

The relation between serum levels of epidermal growth factor and necrotizing enterocolitis in preterm neonates

  • Ahmed, Heba Mostafa (Department of Pediatrics, Faculty of Medicine, Beni-Suef University) ;
  • Kamel, Nsreen Mostafa (Department of Clinical and Chemical Pathology, Faculty of Medicine, Beni-Suef University)
  • Received : 2018.09.22
  • Accepted : 2019.03.14
  • Published : 2019.08.15

Abstract

Purpose: Necrotizing enterocolitis (NEC) is one of the most serious complications of prematurity. Many risk factors can contribute to the development of NEC. The epidermal growth factor (EGF) plays a major role in intestinal barrier function, increases intestinal enzyme activity, and improves nutrient transport. The aim of this study was to assess the role of epidermal growth factor in the development of NEC in preterm neonates. Methods: In this study, 130 preterm neonates were included and divided into 3 groups, as follows: group 1, 40 preterm neonates with NEC; group 2, 50 preterm neonates with sepsis; and group 3, 40 healthy preterm neonates as controls. The NEC group was then subdivided into medical and surgical NEC subgroups. The serum EGF level was measured using enzyme-linked immunosorbent assay. Results: Serum EGF levels (pg/dL) were significantly lower in the NEC group (median [interquartile range, IQR], 9.6 [2-14]) than in the sepsis (10.1 [8-14]) and control groups (11.2 [8-14], P<0.001), with no significant difference between the sepsis and control groups, and were positively correlated with gestational age (r=0.7, P<0.001). A binary logistic regression test revealed that low EGF levels and gestational ages could significantly predict the development of NEC. The receiver-operating characteristic curve for EGF showed an optimal cutoff value of 8 pg/mL, with 73.3% sensitivity, 98% specificity, and an area under the curve of 0.92. Conclusion: The patients with NEC in this study had significantly lower serum EGF levels (P<0.001), which indicated that EGF could be a reliable marker of NEC in preterm neonates.

Keywords

References

  1. Caplan MS, Jilling T. New concepts in necrotizing enterocolitis. Curr Opin Pediatr 2001;13:111-5. https://doi.org/10.1097/00008480-200104000-00004
  2. Neu J, Walker WA. Necrotizing enterocolitis. N Engl J Med 2011;364: 255-64. https://doi.org/10.1056/NEJMra1005408
  3. Stey A, Barnert ES, Tseng CH, Keeler E, Needleman J, Leng M, et al. Outcomes and costs of surgical treatments of necrotizing enterocolitis. Pediatrics 2015;135:e1190-7. https://doi.org/10.1542/peds.2014-1058
  4. Lin PW, Nasr TR, Stoll BJ. Necrotizing enterocolitis: recent scientific advances in pathophysiology and prevention. Semin Perinatol 2008; 32:70-82. https://doi.org/10.1053/j.semperi.2008.01.004
  5. Cho SX, Berger PJ, Nold-Petry CA, Nold MF. The immunological landscape in necrotising enterocolitis. Expert Rev Mol Med 2016;18:e12. https://doi.org/10.1017/erm.2016.13
  6. Bradshaw WT. Necrotizing enterocolitis: etiology, presentation, management, and outcomes. J Perinat Neonatal Nurs 2009;23:87-94. https://doi.org/10.1097/JPN.0b013e318196fefb
  7. Stoll BJ, Hansen NI, Bell EF, Walsh MC, Carlo WA, Shankaran S, et al. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012. JAMA 2015;314:1039-51. https://doi.org/10.1001/jama.2015.10244
  8. Young C, Sharma R, Handfield M, Mai V, Neu J. Biomarkers for infants at risk for necrotizing enterocolitis: clues to prevention? Pediatr Res 2009;65(5 Pt 2):91R-97R. https://doi.org/10.1203/PDR.0b013e31819dba7d
  9. Filleur S, Nelius T, de Riese W, Kennedy RC. Characterization of PEDF: a multi-functional serpin family protein. J Cell Biochem 2009;106: 769-75. https://doi.org/10.1002/jcb.22072
  10. Dvorak B, Halpern MD, Holubec H, Williams CS, McWilliam DL, Dominguez JA, et al. Epidermal growth factor reduces the development of necrotizing enterocolitis in a neonatal rat model. Am J Physiol Gastrointest Liver Physiol 2002;282:G156-64. https://doi.org/10.1152/ajpgi.00196.2001
  11. Kliegman RM, Walsh MC. Neonatal necrotizing enterocolitis: pathogenesis, classification, and spectrum of illness. Curr Probl Pediatr 1987;17:213-88.
  12. Playford RJ, Wright NA. Why is epidermal growth factor present in the gut lumen? Gut 1996;38:303-5. https://doi.org/10.1136/gut.38.3.303
  13. Harris RC, Chung E, Coffey RJ. EGF receptor ligands. Exp Cell Res 2003;284:2-13. https://doi.org/10.1016/S0014-4827(02)00105-2
  14. Guo J, Sheng G, Warner BW. Epidermal growth factor-induced rapid retinoblastoma phosphorylation at Ser780 and Ser795 is mediated by ERK1/2 in small intestine epithelial cells. J Biol Chem 2005;280: 35992-8. https://doi.org/10.1074/jbc.M504583200
  15. Basuroy S, Seth A, Elias B, Naren AP, Rao R. MAPK interacts with occludin and mediates EGF-induced prevention of tight junction disruption by hydrogen peroxide. Biochem J 2006;393(Pt 1):69-77. https://doi.org/10.1042/BJ20050959
  16. Mannon P, Reinisch W. Interleukin 13 and its role in gut defence and inflammation. Gut 2012;61:1765-73. https://doi.org/10.1136/gutjnl-2012-303461
  17. Elliott SN, Wallace JL, McKnight W, Gall DG, Hardin JA, Olson M, et al. Bacterial colonization and healing of gastric ulcers: the effects of epidermal growth factor. Am J Physiol Gastrointest Liver Physiol 2000;278:G105-12. https://doi.org/10.1152/ajpgi.2000.278.1.G105
  18. Shin CE, Falcone RA Jr, Stuart L, Erwin CR, Warner BW. Diminished epidermal growth factor levels in infants with necrotizing enterocolitis. J Pediatr Surg 2000;35:173-6. https://doi.org/10.1016/S0022-3468(00)90005-8
  19. Hofmann GE, Abramowicz JS. Epidermal growth factor (EGF) concentrations in amniotic fluid and maternal urine during pregnancy. Acta Obstet Gynecol Scand 1990;69:217-21. https://doi.org/10.3109/00016349009028683

Cited by

  1. Epidermal growth factor as a reliable marker of necrotizing enterocolitis in preterm neonates vol.63, pp.4, 2019, https://doi.org/10.3345/kjp.2019.00409
  2. The Impact of Maternal Breast Milk in Preventing Necrotizing Enterocolitis: A Narrative Review vol.12, pp.1, 2019, https://doi.org/10.5812/compreped.108704